In a recent study published in npj Antimicrobials and Resistance, researchers addressed the issue of the rise of antifungal drugs-resistant infections and the advent of multidrug-resistant fungal ...
These sample data illustrate how phenotypic profiles can be used to tease out novel drug mechanisms. A team of Harvard scientists has found a high-throughput way to tie drugs with the cellular ...
Direct multi-KRAS inhibitors, QTX3034 and QTX3544, exhibit potent activity against established and novel resistance mechanisms to ...
A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell ...
A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor CB1 has shown promise as a safe and effective treatment for cannabis use disorder (CUD). Tests ...
A new experimental antibiotic can handily knock off one of the world’s most notoriously drug-resistant and deadly bacteria —in lab dishes and mice, at least. It does so with a never-before-seen method ...
Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for ...
Experimental data from FAP-Exd (AVA6103) demonstrates a more favorable profile compared to the marketed Antibody Drug Conjugate (ADC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results